SOUTH AFRICA
|
Party |
Device (CFC MDI, HFC
MDI, or DPI) |
Active Ingredient(s) |
Brand Name |
Manufacture |
Source Party |
Date Authorized for
Marketing (if applicable) |
Data Approved |
Date Launched |
|
South Africa |
CFC MDI |
Beclometasone dipropionate |
Becotide |
GlaxoSmithKline |
UK,Speke |
|
19 May 89 |
|
|
South Africa |
DPI |
Beclometasone dipropionate |
Becotide Rotacaps |
GlaxoSmithKline |
UK, Greenford |
|
1 Oct 82 |
|
|
South Africa |
DPI |
Beclometasone dipropionate |
Becodisk 100 |
GlaxoSmithKline |
Poland, Poznan |
|
12 Apr 90 |
|
|
South Africa |
DPI |
Fluticasone propionate |
Flixotide Accuhaler |
GlaxoSmithKline |
UK, Ware |
|
13 Dec 95 |
|
|
South Africa |
CFC MDI |
Fluticasone propionate |
Flixotide |
GlaxoSmithKline |
Speke, UK |
|
12 Nov 93 |
|
|
South Africa |
HFC MDI |
Fluticasone propionate |
Flixotide |
GlaxoSmithKline |
France Evreux |
|
12 Nov 99 |
|
|
South Africa |
DPI |
Fluticasone propionate |
Flixotide Disk |
GlaxoSmithKline |
France, Evreaux |
|
12 Nov 93 |
1 Dec 93 |
|
South Africa |
DPI |
Fluticasone propionate/salmeterol xinafoate |
Seretide Accuhaler |
GlaxoSmithKline |
UK, Ware |
|
11 Aug 00 |
1 Feb 01 |
|
South Africa |
HFC MDI |
propionate/salmeterol xinafoate |
Seretide Accuhaler |
GlaxoSmithKline |
France,Evreux |
|
2 Feb 02 |
1 Mar 02 |
|
South Africa |
DPI |
Salmeterol xinafoate |
Serevent Accuhaler |
GlaxoSmithKline |
UK, Ware |
|
22 Sep 95 |
9 Jan 96 |
|
South Africa |
CFC MDI |
Salmeterol xinafoate |
Serevent |
GlaxoSmithKline |
UK, Speke |
|
28 Jun 91 |
|
|
South Africa |
DPI |
Salmeterol xinafoate |
Serevent |
GlaxoSmithKline |
France Evreux |
|
26 Jun 91 |
|
|
South Africa |
DPI |
Salbutamol sulphate |
Ventolin Accuhaler |
GlaxoSmithKline |
France, Evreux |
|
22 Apr. 97 |
|
|
South Africa |
CFC MDI |
Salbutamol sulphate |
Ventolin |
GlaxoSmithKline |
South Africa, Midrand |
|
24 Feb 70 |
1 Dec 77 |
|
South Africa |
HFC MDI |
Salbutamol sulphate |
Ventolin |
GlaxoSmithKline |
France Evreux |
|
29 May 00 |
|
|
South Africa |
DPI |
Salbutamol sulphate |
Ventolin |
GlaxoSmithKline |
UK, Greenford |
|
21 Jan 83 |
1 Jan 85 |
|
South Africa |
DPI |
Salbutamol sulphate |
Ventodisks |
GlaxoSmithKline |
France, Evreux |
|
29 Mar 90 |
|
|
Party |
Device (CFC MDI, HFC
MDI, or DPI) |
Active Ingredient(s) |
Brand Name |
Applicant |
Manufacturer |
Date Authorized for
Marketing (if applicable) |
|
South Africa |
CFC MDI |
Ipratropium bromide |
ATROVENT 40 |
Ingelheim Pharmaceuticals (Pty) Ltd. |
Ingelheim Pharmaceuticals, Waltloo,Pretoria |
4 Sep 91 |
|
South Africa |
CFC MDI |
Fenoterol hydrobromide |
BEROTEC 100 MDI |
Ingelheim Pharmaceuticals (Pty) Ltd. |
Boehringer Ingelheim, Reims, France |
6 Aug 91 |
|
South Africa |
CFC MDI |
Ipratropium bromide Salbutamol sulphate |
COMBIVENT MDI |
Ingelheim Pharmaceuticals (Pty) Ltd. |
Boehringer Ingelheim, Reims, France |
7 Jan 95 |
|
South Africa |
CFC MDI |
Ipratropium bromide Fenoterol hydrobromide |
DUOVENT MDI |
Ingelheim Pharmaceuticals (Pty) Ltd. |
Ingelheim Pharmaceuticals, Waltloo, Pretoria |
14 Jan 85 |
|
South Africa |
CFC MDI |
Budesonide |
INFLAMMIDE 50/100/200 mdi |
Ingelheim Pharmaceuticals (Pty) Ltd. |
Ingelheim Pharmaceuticals, Waltloo, Pretoria |
30 Sep 93 |